A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients

Among cancer patients, physical activity interventions can lead to improvements in QOL and
reductions in fatigue and pain. While pancreatic cancer patients may have physical
restrictions that limit their participation in moderate to high-intensity exercise
activities, empirical evidence suggests that even low-intensity, home-based walking programs
can confer benefits for cancer patients. In this pilot study, 50 patients will be randomly
assigned to receive either the walking intervention program or usual care (UC). Assessments
of quality of life, distress, and symptom burden will be completed at baseline
(pre-intervention) and at follow-up (i.e. within 2 weeks post-intervention or approximately
12-14 weeks post-baseline). Data from the proposed pilot study will inform the development of
a larger randomized trial designed to improve QOL and reduce morbidity in this patient
population.

Inclusion Criteria:

- Patients aged 18 years or older

- Have histologically confirmed adenocarcinoma of the pancreas (including adenocarcinoma
subtypes such as signet ring carcinoma, adenosquamous carcinoma,
undifferentiated/poorly differentiated carcinoma, and mucinous carcinoma)

- Have an estimated life expectancy of greater than 3 months

- Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2

- Are undergoing treatment for pancreatic cancer at Fox Chase Cancer Center

- Have borderline resectable or unresectable locally advanced disease or metastatic
disease

Exclusion Criteria:

- Patients with islet cell/neuroendocrine or papillary cystic neoplasm

- Patients scheduled to undergo surgical resection for curative intent during study
participation

- Patients receiving 3rd-line palliative chemotherapy

- Inability to communicate in English.